Recursion to Participate in Upcoming Investor Conferences
- Thursday, March 31, 2022, 7:12
- PR Newswire
- Add a comment
SALT LAKE CITY, March 31, 2022 /PRNewswire/ — Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences: Piper Sandler AI/Machine Learning…
About the Author
admin has written 20022 stories on this site.